DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rose 3.07% to $222.67 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.46% to 7,666.60 and the Dow Jones Industrial Average rising 0.56% to 53,061.95.
The stock's rise snapped a three-day losing streak.
Biogen Inc. closed 0.08% short of its 52-week high of $222.85, which the company achieved on August 25th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 1.48% to $275.21, Pfizer Inc. $(PFE)$ rose 1.65% to $29.02, and AbbVie Inc. $(ABBV)$ rose 0.67% to $261.72.
Trading volume (1.3 M) eclipsed its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.